Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.
Also called NCT03547336
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 212 participants
- Registry
-
NCT03547336
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03547336. Randomized; no masking; primary purpose treatment. Start 2018-06-29 (actual); primary completion 2020-01-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration
- Condition
- End Stage Renal Disease
- Intervention (Device)
- Theranova 400 Dialyzer
- Intervention (Device)
- FX800 Dialyzer
- Lead sponsor
- Vantive Health LLC
- Collaborator
- Baxter Healthcare Corporation
Record details
- Record id
cardio:ct-nct03547336- Content hash
b49aaddb1370c9311f217107171403433351c860d7621cbdf0f26badef25efe2